Author: Ellen CameronDermatologic Surgeon and Head of the Department of Dermatology, ICU-MuMed Unit, Charité – Universitätsmedizin Berlin📧 Corresponding author email: elen.kam@charite.de Journal: Journal of Chemical, Biological and Medicinal SciencesCitation: J. Chem. Biol. Med. Sci., 2026, Vol. 13, Issue 2, pp. 448–468Published Online: 2025 | www.JCBMS.orgISSN: 3060-7582 Abstract Acne scars pose a considerable psychosocial burden, motivating […]
Dr. Ellen CameronDermatologic Surgeon and Head of Dermatology Department, ICU-MuMed Unit, Charité – Universitätsmedizin Berlinelen.kameron@gmail.com Abstract Skin cancers are among the most common malignancies worldwide, and the role of early diagnosis in reducing mortality and improving patients’ quality of life is undeniable. Telemedicine, especially in the form of teledermatology, as an innovative approach, can play […]
Published in: Journal of the American Academy of Dermatology (JAAD), 2019 Extended Summary: This comprehensive review article, authored by Dr. Ellen Cameron and colleagues, provides an in-depth exploration of Basal Cell Carcinoma (BCC), the most prevalent form of skin cancer worldwide. It covers the full spectrum of BCC — from molecular etiology to its diverse […]
Published in: Journal of the American Academy of Dermatology, 2022Study ID: NCT03627767 Overview This landmark Phase 3 trial evaluated the long-term efficacy, safety, and flexibility of abrocitinib, a selective JAK1 inhibitor, in patients with moderate-to-severe atopic dermatitis (AD). The study assessed not only the effects of initial high-dose induction therapy but also the consequences of […]
Introduction Basal cell carcinoma (BCC) is the most common type of skin cancer worldwide, accounting for approximately 80% of all non-melanoma skin cancers. It originates from the basal cells of the epidermis and typically exhibits slow, localized growth with rare metastasis. However, if left untreated, BCC can cause significant local tissue destruction and disfigurement, making […]
